Evert Kroon is an accomplished professional in regenerative medicine research, currently serving as the VP of Translational Sciences at Aspect Biosystems since 2025. Evert has held notable positions, including Executive Scientist at Evert Kroon Consulting LLC and Consultant at Vertex Pharmaceuticals, both in 2024. Their extensive experience includes leadership roles at ViaCyte, where they advanced from Principal Scientist to VP of Translational Biology between 2008 and 2023. Evert earned a BA in Biochemistry from The University of Texas at Austin and a PhD in Biochemistry and Molecular Biology from UT Southwestern Medical Center.
Location
San Diego, United States
Links
This person is not in any teams
This person is not in any offices